QIAGEN and Onto Innovation reported strong Q4 2023 earnings, with QIAGEN’s molecular sample tech and Onto Innovation’s Dragonfly inspection systems driving growth.
Source
QIAGEN and Onto Innovation reported strong Q4 2023 earnings, with QIAGEN’s molecular sample tech and Onto Innovation’s Dragonfly inspection systems driving growth.
Source